PF4 and Thrombocytopenia: Moreover, the same group showed in vivo that IdeS prevented thrombocytopenia and thrombin activation (i.e., HIT) when 5B9 and UFH were administered to transgenic mice expressing human FcγRIIa and PF4 [77].